tm logo
MERMAID BIO
Live/Registered
REGISTERED

on 30 Jul 2019

Last Applicant/ Owned by

100 ENTRADA DR

LOS ALAMOS

NM

87544

Serial Number

88225561 filed on 11th Dec 2018

Registration Number

5819333 registered on 30th Jul 2019

in the Principal Register

Correspondent Address

David S. Kerr

DAVID S. KERR BERG HILL GREENLEAF RUSCITTI LLP

BOULDER, CO 80302

UNITED STATES

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

MERMAID BIO

Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit pathogens directed to aquatic organism; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit pathogens directed to aquatic Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit pathogens directed to aquatic organism; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit pathogens directed to aquatic organism grown in aquaculture; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms grown in aquaculture; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms grown in aquaculture; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit bacterial quorum-sensing Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit bacterial quorum-sensing; Research and development of new biological products for therapeutic use to prevent or treat aquatic diseases; Research and development of new biological products for therapeutic use to prevent or treat diseases affecting animals grown in aquaculture


First Use Date in General

04th Dec 2018

First Use Date in Commerce

04th Dec 2018

Mark Details


Serial Number

No 88225561

Mark Type

No Service Mark

Attorney Docket Number

No 90115.00400

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
30th Jul 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06th Jan 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09th Oct 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
30th Jul 2019REGISTERED-PRINCIPAL REGISTER
14th May 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14th May 2019PUBLISHED FOR OPPOSITION
24th Apr 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10th Apr 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
05th Apr 2019ASSIGNED TO LIE
14th Mar 2019APPROVED FOR PUB - PRINCIPAL REGISTER